Privium Fund Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-114,024	Closed	-$3.3M	–	135
2024 Q1	$3.3M	Buy	+114,024	New	+$3.3M	0.88%	28